Latest market headlines for GLENMARK on Terminal.
06-Jul-2026 08:38:38
• Glenmark Pharmaceuticals Inc., USA has launched Olanzapine for Injection, 10 mg/vial, Single-Dose Vial. • The product is bioequivalent and therapeutically eq…
02-Jul-2026 08:37:12
• Glenmark Specialty S.A. announced the advancement of its multi-country Phase 3 clinical trial for Trastuzumab rezetecan (SHR-A1811) for patients with platinu…
12-Jun-2026 19:06:12
Buy, TP raised to Rs 2750 Analyst day takeaways, GLEN is confident of driving 13-15% sales growth & 100bps margin improvement to FY30 led by Branded biz with I…